Published on : Apr 07, 2016
Vitreous tamponades are used in vitrectomy procedures that are conducted on the human eye, which assist in healing the retina or reattachment of the retina. These procedures also help provide a replacement for the clouded vitreous humor. The vitreous humor of the eye tears up or starts getting detached from the retina due to ageing process or due to some trauma. Thus, a vitrectomy procedure that replaces the vitreous humor with a synthetic substitute is done after the removal of the vitreous humor.
According to a report published by market experts, Transparency Market Research, the global vitreous tamponades market which was valued at US$64.5 bn in 2014, is will expand to reach a value of US$77.5 bn by the end of 2020.
Growing Geriatric Population Boosts Global Vitreous Tamponades Market
The global vitreous tamponade market is expected to grow at a moderate rate owing to an increase in the cases of retinal detachments. Moreover, the growth of geriatric population worldwide, is also helping the expansion of the vitreous tamponades market. Additionally, the occurrence of diabetic retinopathy, macular pucker, and similar other retinal disorders are driving the global vitreous tamponade market.
Gaseous Tamponades to Expand at the fastest rate in Future
The liquid tamponades market was the leading segment accounting for 49% of the global market. The growth was attributed to the wide use of liquid tamponades over gaseous ones in the Asian and European regions. The liquid tamponades were used to treat retinal detachments with multiple breaks and proliferative vitreoretinopathy. However, in the future, the gaseous tamponades segment is expected to grow at a faster rate due to the ease of use and lower rates.